title: Trends in the stem cell and regenerative medicine industry.
abstract: The World Stem Cell Regenerative Medicine Congress series, now in its 7th year, is organized annually in the USA, Europe and Asia by Terrapinn, a business media company with its head office in London, and has grown over the last several years into the largest and probably the most important strategic stem cell conference where regulators, investors, big pharma, and small and medium enterprises gather to share and create synergy in developing and commercializing stem cell applications. The conference, held in London on 21-23 May 2012, only confirmed that this series is the meeting to attend if you want to get a clear understanding of trends in the stem cell and regenerative medicine industry.
authors.affiliation: Human Embryonic Stem Cell Laboratories, Guy's Assisted Conception Unit, Division of Women's Health, King's College London School of Medicine, London, UK. dusko.ilic@kcl.ac.uk
authors.forename: Dusko
authors.initials: D
authors.lastname: Ilic
mesh_terms: D002986:Clinical Trials as Topic / Q000191:economics; D003625:Data Collection; D055808:Drug Discovery; D004345:Drug Industry / Q000191:economics / Q000639:trends; D006801:Humans; D007449:Investments; D044968:Regenerative Medicine / Q000191:economics / Q000331:legislation & jurisprudence / Q000639:trends*; D012109:Research Support as Topic / Q000191:economics; D057905:Stem Cell Research / Q000191:economics / Q000331:legislation & jurisprudence; D013234:Stem Cells / Q000166:cytology*; D057170:Translational Research, Biomedical / Q000331:legislation & jurisprudence